“Association between Interleukin-6 Levels, Rituximab Response, and Disease Activity in Patients with Rheumatoid Arthritis”, AJPS, vol. 25, no. 3, pp. 455–461, Aug. 2025, doi: 10.32947/ajps.v25i3.1225.